Comment
doi: 10.1016/S1470-2045(14)70198-6.
Epub 2014 Aug 19.
The ProtecT trial: what can we expect?
Affiliations
- PMID: 25163904
- DOI: 10.1016/S1470-2045(14)70198-6
Item in Clipboard
Comment
The ProtecT trial: what can we expect?
Lancet Oncol.
2014 Sep.
Free article
Erratum in
- Lancet Oncol. 2014 Oct;15(11):e475
No abstract available
Comment on
-
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.Lancet Oncol. 2014 Sep;15(10):1109-18. doi: 10.1016/S1470-2045(14)70361-4. Epub 2014 Aug 19. Lancet Oncol. 2014. PMID: 25163905 Clinical Trial.
Similar articles
-
Clinical trials: ProtecT-ing against prostate cancer.Nat Rev Urol. 2014 Nov;11(11):601. doi: 10.1038/nrurol.2014.249. Epub 2014 Sep 9. Nat Rev Urol. 2014. PMID: 25201617 No abstract available.
-
'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?BJU Int. 2017 Apr;119(4):513-514. doi: 10.1111/bju.13734. Epub 2017 Jan 4. BJU Int. 2017. PMID: 27930856 No abstract available.
-
Prostate cancer: Time for active surveillance of intermediate-risk disease?Nat Rev Urol. 2013 Jan;10(1):6-8. doi: 10.1038/nrurol.2012.213. Epub 2012 Nov 13. Nat Rev Urol. 2013. PMID: 23147924 No abstract available.
-
Active surveillance and radical prostatectomy.Eur J Cancer. 2011 Sep;47 Suppl 3:S355-6. doi: 10.1016/S0959-8049(11)70201-5. Eur J Cancer. 2011. PMID: 21944013 Review. No abstract available.
-
[Focal therapy for prostate cancer in Germany - 2014 status].Urologe A. 2014 Jul;53(7):1040-5. doi: 10.1007/s00120-014-3532-2. Urologe A. 2014. PMID: 24941932 Review. German.
Cited by
-
Comparison of clinical and survival characteristics between prostate cancer patients of PSA-based screening and clinical diagnosis in China.Oncotarget. 2017 Sep 8;9(1):428-441. doi: 10.18632/oncotarget.20787. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416625 Free PMC article.
-
Radical prostatectomy versus deferred treatment for localised prostate cancer.Cochrane Database Syst Rev. 2020 Jun 4;6(6):CD006590. doi: 10.1002/14651858.CD006590.pub3. Cochrane Database Syst Rev. 2020. PMID: 32495338 Free PMC article.
-
Organ-confined prostate cancer: are we moving towards more or less radical surgical intervention?Curr Urol Rep. 2015 May;16(5):27. doi: 10.1007/s11934-015-0504-z. Curr Urol Rep. 2015. PMID: 25773349 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
